4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-045972
EVP & Chief Commercial Officer sold 375 shares at $91.53 ($34,324)
From the SEC's structured data for this filing
Trades in this filing
Harris Erik · EVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-06 | Sale : show line 1 in the form | −375 | $91.53 | $34,324 | 25,333 | D |
| Open-market sales · 375 sh · avg $91.53 · $34,324 | ||||||
Loading xslF345X03/doc4.xml…